Acupuncture for chronic insomnia with mild cognitive impairment: protocol for a randomized controlled trial - Top-Institutions - MDSpire

Acupuncture for chronic insomnia with mild cognitive impairment: protocol for a randomized controlled trial

  • By

  • Xueqian Jia

  • Gongyue Zhou

  • Pei Shen

  • Sangyi Lin

  • Haijiang Zhou

  • Fu Xu

  • Shuo Jiang

  • Cong Wang

  • June 19, 2026

  • 0 min

Share

Top Institutions in Neurology

Brief introduction explaining scope and methodology.

  • #1

    Zhejiang Chinese Medical University
    Zhejiang Chinese Medical University

    Hangzhou, China

    Key Differentiators

    • Acupuncture
    • Sleep Medicine

  • #2

    Hospital of Chengdu University of Traditional Chinese Medicine
    Hospital of Chengdu University of Traditional Chinese Medicine

    Chengdu, China

    Key Differentiators

    • Acupuncture
    • Sleep Medicine

  • #3

    American Academy of Sleep Medicine
    American Academy of Sleep Medicine

    Darien, Illinois

    Key Differentiators

    • Sleep Medicine

  • #4

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, New York

    Key Differentiators

    • Oncology
    • Sleep Medicine

  • #5

    UC Irvine School of Pharmacy & Pharmaceutical Sciences
    UC Irvine School of Pharmacy & Pharmaceutical Sciences

    Irvine, California

    Key Differentiators

    • Pharmacy
    • Sleep Medicine

Original Source(s)

Acupuncture for chronic insomnia with mild cognitive impairment: protocol for a randomized controlled trial

  • by Xueqian Jia, Gongyue Zhou, Pei Shen, Sangyi Lin, Haijiang Zhou, Fu Xu, Shuo Jiang, Cong Wang

  • June 19, 2026

Related Content

Treatable Pediatric Neuromuscular Disorders

Through a case-based, evidence-driven approach, this Neuroscience Grand Rounds session highlights how clinicians can differentiate among neuromuscular conditions, localize disease processes and identify those disorders where timely treatment can significantly alter disease trajectory.

  • June 19, 2026

  • 1 min
Neural regulation of tumor progression: implications for hepatocellular carcinoma

Clinical outcomes and safety of efgartigimod in Guillain–Barré syndrome: a retrospective observation study